Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002116
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase III Study of the Safety and Efficacy of Topical 1-S-3-Hydroxy-2-PhosphonylmethoxypropylCytosine Dihydrate Cidofovir HPMPC in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS
Sponsor:
Gilead Sciences
Organization:
NIH AIDS Clinical Trials Information Service